67 %
33 %
Information about VISX

Published on May 2, 2008

Author: Natalia



VISX “We Make Things Clear”:  VISX “We Make Things Clear” VISX Burns:  VISX Burns On fire since its debut April 1998 11 consecutive profitable quarters. Stock performance as miraculous as the 20/20 vision its technology brings to the eyes. In 1998, investors saw their VISX stock rise 295%. This year the stock is up more than 205%, even though it is down considerably from its July highs. Company Background:  Company Background Founded in 1986 FDA approved in 1995 140 Woldwide Pattents 70 Still Pending Profits:  Profits 1. World wide sale of lasers 2. Servicing and parts sales 3. $250 commission per operation VisionKey card 4. Licensing of procedures and equipment Lasers:  Lasers Excimer Lasers treat: nearsightedness astigmatisms farsightedness Star S2 Laser Only US laser approved in Japan Over 60 countries Management:  Management Mark B Logan Served major health companies Bausch & Lomb Has been CEO since 1994 Competition:  Competition Summit Bausch & Lomb Keravision Nidek Why you should NOT buy:  Why you should NOT buy Market cap is $2 billion more than Bausch & Lomb Pricing War? Customers are fixed and don’t come back loose perpetual royalty of maintenance KeraVision Intacts? Reversible surgery Nidek litigation Why you should buy:  Why you should buy What competition? VISX has 70-80% of the market Intacts are only approved for very low myopics very small portion of the market Nidek Litigation:  Nidek Litigation VISX WIN= it would be a significant positive for the stock. VISX LOSS= not much will change, except that Nidek will be able to sell its machines in the U.S. VISX will continue to sue doctors who use Nidek. Not convinced?:  Not convinced? Market Scope, the leading independent source of information in the refractive surgical market, recently released its annual survey of refractive surgeons. When asked what they expect to be using two years from now, the responses came in as follows: VISX 60.9%, Keravision Intacs 49.1%, Sunrise Holmium 32.5%, Nidek 19.2%, and Summit 13.7%. Why VISX?:  Why VISX? Out performs analyst expectations 60% of lasers intalled Performs 70-80% operations annually NO LONG TERM DEBT Celebrity Endorsement Tiger Woods Greg Maddux Estimated 30% earnings growth in 2000 Market:  Market 157 million Americans would benefit from laser surgery they spend 13 billion annually on eye care ONLY 1 million have received laser surgery Market Growth:  Market Growth 400,000 procedures last year 900,000 predicted this year Income Statement:  Income Statement 12-month sales: $238.1 million 12-month income: $83.2 million* 12-month EPS: $1.23* Profit Margin: 34.9% Market Cap: $5045.2 million (*Includes non-recurring items) Balance Sheet :  Balance Sheet Cash: $77.6 million Current Assets: $310.4 million Current Liabilities: $50.5 million Long-term Debt: None Balance Sheet :  Balance Sheet Cash: $77.6 million Current Assets: $310.4 million Current Liabilities: $50.5 million Long-term Debt: None Ratios Price-to-earnings: 59.7 Price-to-sales: 21.2 QUESTIONS?:  QUESTIONS?

Add a comment

Related presentations

Related pages

VISX, Incorporated

Designs, develops and manufactures excimer refractive surgical systems designed to recontour the front surface of the cornea of the human eye. (Nasdaq: VISX).
Read more

VISX Star S4 IR Active Trak - Laser Eye Surgery, LASIK ...

VISX Star S4 IR Active Trak . This excimer laser system is the latest generation of VISX technology. It incorporates many new and exciting technology features:
Read more

VISX News | Nachrichten zur VISX Aktie |

VISX News: Hier finden Sie alle VISX News und Nachrichten zur VISX Aktie.
Read more

Abbott Medical Optics

You have clicked an external link and are about to leave Abbott Medical Optics Inc.'s division website.
Read more

STAR S4 IR® Excimer Laser - Abbott Medical Optics

The VISX STAR S4 IR Excimer Laser System with VSS and WaveScan WaveFront System are approved to perform wavefront-guided laser assisted in-situ ...
Read more

VSX Stock Quote - Visx Inc - Bloomberg Markets

Stock analysis for Visx Inc (VSX) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Read more

VISX Aktie: Aktienkurs, Chart & News (877565 | US92844S1050)

VISX (877565 | US92844S1050) mit aktuellem Aktienkurs, Charts, News und Analysen.
Read more

VISX AKTIE | Aktienkurs | Nachrichten | Kurs | (877565,EYE ...

VISX AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie VISX Inc. | 877565 | EYE
Read more

Laser Eye Surgery, Contacts, and Contacts For Astigmatism ...

Frequently Asked Questions VISX CustomVue Laser Vision Procedure. What is VISX CustomVue (individualized laser vision) correction? Who is a candidate for ...
Read more